https://www.biospace.com/neuroscience-psychedelic-company-delix-therapeutics-secures-70-million-in-financing
Delix Therapeutics Scores $70 Million for Non-hallucinogenic Psychedelic Analogs - BioSpace
Sep 27, 2021 - The company aims to treat different forms of mental illness and brain disorders with its pipeline.
delix therapeutics70 millionscores